Skin Biopsy Market Research Report - Global forecast till 2027

Skin Biopsy Market Information: By Type (Shave Biopsy, Excisional Biopsy, Incisional Biopsy), Device (Needle Based Biopsy Guns, Biopsy Forceps, Biopsy Needles), Indication (Cancer, Actinic Keratosis, Skin Infection), End User - Global Forecast till 2027

ID: MRFR/MED/3229-HCR | February 2021 | Region: Global | 110 pages

Please note that the assessment period of report has been updated from 2018-2025 to 2020-2027. Cordially fill the sample form for updated data

Market Synopsis of the Global Skin Biopsy Market


Skin biopsy is a procedure involving the removal of skin for examination and providing information about any disease or clinical conditions. It is performed to determine the presence of any cancerous cells or any type of skin diseases. Skin cancer, actinic keratosis, dermatitis, psoriasis, and skin infection are various diseases that can be diagnosed through skin biopsy. During the procedure, the sample taken from the affected or diseased part of the skin is placed in formaldehyde solution, the tissue is processed and then examined under the microscope. 


Rising of skin cancer and number of skin disease such as psoriasis, viral skin infection, and dermatitis, and growing demand for minimally invasive medical procedures are major factors contributing to the market growth. Furthermore, rising expenditure on the medical devices and instruments boost the market growth. However, high cost of treatment for skin diseases restrains the market.


The global skin biopsy market is expected to grow at a CAGR of 9.4% during the forecast period.


FIGURE 1: Global Skin Biopsy Market by Region, 2016 (%) Skin Biopsy Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation 


Key Players in the Global Skin Biopsy Market 

Some of the key players in this market are Boston Scientific Corporation (U.S.), COOK Medical (U.S.), BD (U.S.), DTR Medical Ltd (U.K), Devicor Medical Products, Inc. part of Leica Biosystems. (U.S.), Gallini Srl (Italy), Hologic, Inc. (U.S.), and Cardinal Health (U.S.).


 Segments                                                                                                                                            


The global skin biopsy market is segmented on the basis of type, devices, indication, and end user.


On the basis of type, market is segmented into shave biopsy, punch biopsy, excisional biopsy and incisional biopsy.


On the basis of devices, the market is segmented into needle based biopsy guns, biopsy curettes and punches, guidance systems, biopsy forceps, biopsy needles and others.


On the basis of indication, the market is segmented into actinic keratosis, dermatitis, psoriasis, skin infection, cancer, and others.


 Skin infection is further segmented into viral infections, deep fungal infections, basal cell carcinoma, squamous cell carcinoma, and melanoma.


On the basis of end user, the market is segmented into hospitals, dermatology clinics, and others.


Research Methodology Skin Biopsy Market-


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


 


 


Regional Analysis of the Global Skin Biopsy Market               


America secures a leading position in the market for skin biopsy owing to the rising prevalence of skin diseases and cancer in the U.S. and presence of key market players. According to the American Academy of Dermatology (AAD), skin diseases affects one in every fourth American. The prevalence of skin diseases is also found to be increasing in Canada.


Europe is the second largest market for skin biopsy. Increasing prevalence of skin diseases such as fungal infections, and dermatitis, and increasing demand for technological advanced diagnostic services further drive the market growth.


The market in Asia Pacific is expected to grow at the fastest pace and is driven by the rising geriatric population, rising prevalence of skin cancer, and increasing number of biopsies performed in the hospitals.


The Middle East & Africa also show a steady rise in the market owing to increasing prevalence of diabetes and other chronic diseases


Intended Audience



  • Biopsy Devices Manufacturers

  • Biopsy Devices Suppliers

  • Private Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Government Research Laboratories



Frequently Asked Questions (FAQ) :


Skin biopsy market is projected to grow at approximately 9.4 %CAGR during the assessment period (2017-2023).

Increasing prevalence of skin diseases, rising awareness about skin cancer & its treatment, and growing demand for technologically advanced medical devices, are the major tailwinds pushing the growth of the global skin biopsy market.

High cost of treatment for skin diseases is a major growth impeder for the global skin biopsy market.

North America holds the largest share in the global skin biopsy market, followed by Europe and the Asia Pacific, respectively.

COOK Medical (U.S.), Boston Scientific Corporation (U.S.), BD (U.S.), Devicor Medical Products, Inc. part of Leica Biosystems. (U.S.), DTR Medical Ltd (U.K), Gallini Srl (Italy), Cardinal Health (U.S.), and Hologic, Inc. (U.S.), are some of the top players operating in the global skin biopsy market.

Table Of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Skin Biopsy Market, By Type

6.1 Introduction

6.2 Shave Biopsy

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Punch Biopsy

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Excisional Biopsy

6.4.1 Market Estimates & Forecast, 2020-2027

6.5 Incisional Biopsy

6.5.1 Market Estimates & Forecast, 2020-2027

7. Global Skin Biopsy Market, By Devices

7.1 Introduction

7.2 Needle Based Biopsy Guns

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Biopsy Curettes And Punches

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Guidance Systems

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Biopsy Forceps

7.5.1 Market Estimates & Forecast, 2020-2027

7.6 Biopsy Needles

7.6.1 Market Estimates & Forecast, 2020-2027

8. Global Skin Biopsy Market, By Indication

8.1 Introduction

8.2 Actinic Keratosis

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Dermatitis

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Psoriasis

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Skin Infection

8.5.1 Market Estimates & Forecast, 2020-2027

8.6 Cancer

8.6.1 Market Estimates & Forecast, 2020-2027

9. Global Skin Biopsy Market, By End User

9.1 Introduction

9.2 Hospital

9.2.1 Market Estimates & Forecast, 2020-2027

9.3 Dermatology Clinics

9.3.1 Market Estimates & Forecast, 2020-2027

10. Global Skin Biopsy Market, By Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 UK

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest Of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic Of Korea

10.4.6 Rest Of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest Of The Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 BOSTON SCIENTIFIC CORPORATION

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 COOK Medical

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 BD

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Cardinal Health

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Hologic, Inc.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial Overview

12.5.4 Key Developments

12.6 DTR Medical Ltd

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Devicor Medical Products, Inc. Part Of Leica Biosystems

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Gallini Srl

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Others

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs Of The Market

13.2 Key Companies To Watch

13.3 Prediction Of Pharmaceutical Industry

14 Appendix

LIST OF TABLES

Table 1 Skin Biopsy Industry Synopsis, 2020-2027

Table 2 Global Skin Biopsy Market Estimates And Forecast, 2020-2027, (USD Million)

Table 3 Global Skin Biopsy Market By Region, 2020-2027, (USD Million)

Table 4 Global Skin Biopsy Market By Types, 2020-2027, (USD Million)

Table 5 Global Skin Biopsy Market By Devices, 2020-2027, (USD Million)

Table 6 Global Skin Biopsy Market By Indication, 2020-2027, (USD Million)

Table 7 Global Skin Biopsy Market By End Users, 2020-2027, (USD Million)

Table 8 North America Skin Biopsy Market By Types, 2020-2027, (USD Million)

Table 9 North America Skin Biopsy Market By Devices, 2020-2027, (USD Million)

Table 10 North America Skin Biopsy Market By Indication, 2020-2027, (USD Million)

Table 11 North America Skin Biopsy Market By End Users, 2020-2027, (USD Million)

Table 12 US Skin Biopsy Market By Types, 2020-2027, (USD Million)

Table 13 US Skin Biopsy Market By Devices, 2020-2027, (USD Million)

Table 14 US Skin Biopsy Market By Indication, 2020-2027, (USD Million)

Table 15 US Skin Biopsy Market By End Users, 2020-2027, (USD Million)

Table 16 Canada Skin Biopsy Market By Types, 2020-2027, (USD Million)

Table 17 Canada Skin Biopsy Market By Devices, 2020-2027, (USD Million)

Table 18 Canada Skin Biopsy Market By Indication, 2020-2027, (USD Million)

Table 19 Canada Skin Biopsy Market By End Users, 2020-2027, (USD Million)

Table 20 South America Skin Biopsy Market By Types, 2020-2027, (USD Million)

Table 21 South America Skin Biopsy Market By Devices, 2020-2027, (USD Million)

Table 22 South America Skin Biopsy Market By Indication, 2020-2027, (USD Million)

Table 23 South America Skin Biopsy Market By End Users, 2020-2027, (USD Million)

Table 24 Europe Skin Biopsy Market By Types, 2020-2027, (USD Million)

Table 25 Europe Skin Biopsy Market By Devices, 2020-2027, (USD Million)

Table 26 Europe Skin Biopsy Market By Indication, 2020-2027, (USD Million)

Table 27 Europe Skin Biopsy Market By End Users, 2020-2027, (USD Million)

Table 28 Western Europe Skin Biopsy Market By Types, 2020-2027, (USD Million)

Table 29 Western Europe Skin Biopsy Market By Devices, 2020-2027, (USD Million)

Table 30 Western Europe Skin Biopsy Market By Indication, 2020-2027, (USD Million)

Table 31 Western Europe Skin Biopsy Market By End Users, 2020-2027, (USD Million)

Table 32 Eastern Europe Skin Biopsy Market By Types, 2020-2027, (USD Million)

Table 33 Eastern Europe Skin Biopsy Market By Devices, 2020-2027, (USD Million)

Table 34 Eastern Europe Skin Biopsy Market By Indication, 2020-2027, (USD Million)

Table 35 Eastern Europe Skin Biopsy Market By End Users, 2020-2027, (USD Million)

Table 36 Asia Pacific Skin Biopsy Market By Types, 2020-2027, (USD Million)

Table 37 Asia Pacific Skin Biopsy Market By Devices, 2020-2027, (USD Million)

Table 38 Asia Pacific Skin Biopsy Market By Indication, 2020-2027, (USD Million)

Table 39 Asia Pacific Skin Biopsy Market By End Users, 2020-2027, (USD Million)

Table 40 Middle East & Africa Skin Biopsy Market By Types, 2020-2027, (USD Million)

Table 41 Middle East & Africa Skin Biopsy Market By Devices, 2020-2027, (USD Million)

Table 42 Middle East & Africa Skin Biopsy Market By Indication, 2020-2027, (USD Million)

Table 43 Middle East & Africa Skin Biopsy Market By End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Skin Biopsy Market

Figure 3 Segmentation Market Dynamics For Skin Biopsy Market

Figure 4 Global Skin Biopsy Market Share, By Devices 2020

Figure 5 Global Skin Biopsy Market Share, By Indication 2020

Figure 6 Global Skin Biopsy Market Share, By End Users, 2020

Figure 7 Global Skin Biopsy Market Share, By Region, 2020

Figure 8 North America Skin Biopsy Market Share, By Country, 2020

Figure 9 Europe Skin Biopsy Market Share, By Country, 2020

Figure 10 Asia Pacific Skin Biopsy Market Share, By Country, 2020

Figure 11 Middle East & Africa Skin Biopsy Market Share, By Country, 2020

Figure 12 Global Skin Biopsy Market: Company Share Analysis, 2020 (%)

Figure 13 BOSTON SCIENTIFIC CORPORATION: Key Financials

Figure 14 BOSTON SCIENTIFIC CORPORATION: Segmental Revenue

Figure 16 BOSTON SCIENTIFIC CORPORATION: Geographical Revenue

Figure 17 COOK Medical: Key Financials

Figure 18 COOK Medical: Segmental Revenue

Figure 19 COOK Medical: Geographical Revenue

Figure 20 BD: Key Financials

Figure 21 BD: Segmental Revenue

Figure 22 BD: Geographical Revenue

Figure 23 Cardinal Health: Key Financials

Figure 24 Cardinal Health: Segmental Revenue

Figure 25 Cardinal Health: Geographical Revenue

Figure 26 DTR Medical Ltd : Key Financials

Figure 27 DTR Medical Ltd : Segmental Revenue

Figure 28 DTR Medical Ltd : Geographical Revenue

Figure 29 Hologic, Inc.: Key Financials

Figure 30 Hologic, Inc.: Segmental Revenue

Figure 31 Hologic, Inc.: Geographical Revenue

Figure 32 Pfizer Inc: Key Financials

Figure 33 Pfizer Inc: Segmental Revenue

Figure 34 Pfizer Inc: Geographical Revenue